Orchestra BioMed Holdings, Inc. Revenue 2022–2025

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

Orchestra BioMed Holdings, Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Orchestra BioMed Holdings, Inc. revenue for the quarter ending March 31, 2026 was 110000, a 87.33% decrease year-over-year.
Orchestra BioMed Holdings, Inc. revenue for the twelve months ending March 31, 2026 was 2.7 M, a 4.60% decrease year-over-year.
Orchestra BioMed Holdings, Inc. annual revenue for 2025 was 33.5 M, a 1169.22% increase from 2024.
Orchestra BioMed Holdings, Inc. annual revenue for 2024 was 2.6 M, a 4.42% decrease from 2023.
Orchestra BioMed Holdings, Inc. annual revenue for 2023 was 2.8 M, a 21.88% decrease from 2022.
Orchestra BioMed Holdings, Inc. annual revenue for 2022 was 3.5 M.

Revenue

TRAILING 12 MONTHS · $B

QUARTERLY · $B

YEAR-OVER-YEAR GROWTH · %

Orchestra BioMed Holdings, Inc. Market Cap — FAQ

Orchestra BioMed Holdings, Inc. (OBIO) market cap over the last 4 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see OBIO's market cap history?

The chart and table above show Orchestra BioMed Holdings, Inc.'s market cap by year and by quarter, including the growth rate.